Forum for Science, Industry and Business
Sponsored by:     Siemens  n-tv 
Search our Site:

Topic (optional):

 

Home Reports Health and Medicine Content

Non-BRCA1/2 Hereditary Breast Cancer Linked to New Cancers

next article
14.02.2006

 


The risk for a new cancer in the unaffected breast substantially increases in women diagnosed with unilateral, hereditary (non-BRCA1/2) breast cancer, according to a new study by researchers working at Karolinska Institutet in Stockholm, Sweden. The study is the first in its kind and is published in the March 15, 2006 issue of CANCER.


Women with hereditary (non-BRCA1/2) breast cancer are estimated to be at up to six times greater risk of developing a second primary malignancy in the other breast, also known as contralateral breast cancer (CBC), than the general population is of developing primary breast cancer. Young age at first diagnosis, family history of breast cancer, and confirmed BRCA1 or BRCA2 gene mutations are the primary risk factors for CBC. However, the contribution of non-BRCA1/2 hereditary cancers to the risk of CBC is poorly understood.

A group of researchers at Karolinska Institutet and Umeå Universitet in Sweden reviewed data from 120 families and 204 women with unilateral breast cancer and a family history of breast cancer but no BRCA mutations to better characterize the CBC risk for these women.

They found that the long term CBC risk was significantly higher in women with hereditary breast cancer compared to the risk of developing a primary breast cancer in the general population. The overall probability for these women was 5.5 percent at 5 years and up to 27.3 percent at 20 years compared to only 1.9 percent at 5 years and 4.9 percent at 20 years for the general population. Further analysis by age group showed clearly that the 15 year probability of developing a CBC was significantly elevated for women with a diagnose before age 50 compared to women at an older age (40 percent and 10 percent, respectively).

Women who received adjuvant hormonal therapy had significantly lowered risk for a CBC compared to those who did not take it. Adjuvant chemotherapy had no apparent effect on risk.

Source: alphagalileo
Further information: www.ki.se

next article

More articles from Health and Medicine:

nachricht Interferon alpha can delay full onset of type I diabetes
03.07.2009 | University of Texas Health Science Center at Houston

nachricht Infants should be screened for hip trouble
03.07.2009 | American Academy of Orthopaedic Surgeons

All articles from Health and Medicine >>>

B2B Search

Product / Service
Company / Organisation

Latest News

The least sea ice in 800 years

03.07.2009 | Earth Sciences

Astronomer's new guide to the galaxy: largest map of cold dust revealed

03.07.2009 | Physics and Astronomy

Interferon alpha can delay full onset of type I diabetes

03.07.2009 | Health and Medicine

VideoLinks

Event News

New Worlds - New Solutions - Research and Innovation as a Basis for Developing Europe in a Global Context

29.06.2009 | Event News

6th BMBF Forum for Sustainability "Research for Sustainability - One Step Further"

19.06.2009 | Event News

2nd ISPIM Innovation Symposium - Stimulating Recovery The Role of Innovation Management

02.06.2009 | Event News